论文部分内容阅读
对用不同方法治疗的126例甲亢患者进行回顾性分析。结果131I治疗治愈率为62.1%,好转率为36.2%,复发率为5.2%,甲低率为20.7%,无效率为1.7%,死亡率为0%;抗甲状腺(ATD)治疗方法治愈率为32.3%,好转率为63.1%,复发率为18.5%,甲低率为3.1%,无效率为4.6%,死亡率为1.5%;手术治疗因例数少,未进行各种率的计算。结论131I治疗是治疗甲亢的较隹方案,可以作为一线治疗方案。
Retrospective analysis of 126 cases of hyperthyroidism treated with different methods. Results The cure rate of 131I treatment was 62.1%, the improvement rate was 36.2%, the recurrence rate was 5.2%, the hypothyroidism rate was 20.7%, the inefficiency rate was 1.7% and the mortality rate was 0%. The anti-thyroid (ATD) treatment rate was The rate of improvement was 63.1%, the recurrence rate was 18.5%, the rate of hypothyroidism was 3.1%, the rate of inefficiency was 4.6% and the rate of death was 1.5%. Conclusion 131I treatment is a more hyperthyroidism 隹 program, can be used as a first-line treatment.